Consequences, Opportunities and Challenges of Modern Biotechnology for Europe
Modern biotechnology products and processes are an integral part of the EU economy, mainly in manufacturing, including pharmaceuticals, agro-food and healthcare. While some products are not recognizable to the broader public (e.g. the use of genetic markers in livestock breeding), others are used on a daily basis (detergents with enzymes, recombinant insulin) or have become subject of public discussion (e.g. genetically modified crops). Modern bioetchnology contributes significantly to the achievement of major EU polciy objectives.
BOCK Anne-Katrin;
PAPATRYFON Ilias;
ZIKA Eleni;
WOLF Oliver;
GOMEZ BARBERO Manuel;
STEIN Alexander Jivraj;
2007-04-18
European Commission
JRC36951
978-92-79-05362-7,
1018-5593,
EUR 22728 EN,
OP LF-NA-22728-EN-C,
Additional supporting files
| File name | Description | File type | |
|---|
